Delivery Order SPE2DB22D2007-SPE2DB24FJ0DK
Award Date 3/4/24
Potential Completion Date 3/25/24
Potential Value $1.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a Firm Fixed Price Delivery Order contract worth $3,373.68 by the Defense Logistics Agency (DLA) to provide HYPERRAB 300 UNIT/ML VIAL 3ML pharmaceuticals. The contract has a completion date of March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside designations. The company also holds an Indefinite Delivery Contract with DLA worth up to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $4,466.28 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide pharmaceutical products, including HYPERRAB 300 UNIT/ML VIALML. This delivery order has a performance period through March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) also awarded by DLA, with a potential value of $999,999,999.00 and a performance...
- The U.S. Defense Logistics Agency (DLA) has awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $8,996.48, is for the supply of HYPERRAB 300 UNIT/ML VIAL 3ML, a medical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HYPERRAB 300 UNIT/ML VIALML pharmaceutical products. The $3,721.90 Firm Fixed Price contract has an ultimate completion date of May 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $7,513.40 award is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a specialty pharmaceutical product. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a $37,567.00 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $9,391.75 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product, to Conshohocken, Pennsylvania by March 12, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $18,609.50, is for the supply of HYPERRAB 300 UNIT/ML VIAL medical products. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of pharmaceutical and medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML medical products. The $11,031.48 firm fixed price contract has a completion date of March 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor. The $1,878.35 firm-fixed price delivery order is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to...